Abraham, Fruchter & Twersky LLP Investigating Claims on Behalf of Investors of DiDi Global Inc. (NYSE:DIDI)
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky LLP is investigating claims on behalf of shareholders of DiDi Global (“DiDi” or the “Company”) for potential violations of federal securities laws.
On July 2, 2021, the Cyberspace Administration of China announced that it is investigating DiDi to protect national security and the public interest, and stated that it had asked DiDi stop new user registrations during the course of the investigation. Following this news, the Company’s American Depositary Shares (“ADS”) price fell 5% to close at $15.53 per ADS on July 2, 2021. On July 4, 2021, Reuters published a report titled, “Didi app suspended in China over data protection,” which reported that “China’s cyberspace administration . . . had ordered smartphone app stores to stop offering the ride-hailing firm Didi Global Inc's app after finding that Didi had illegally collected users’ personal data.”
If you would like to discuss this class action lawsuit or obtain more information about your rights, please contact Abraham, Fruchter & Twersky LLP by e-mailing Jack G. Fruchter (JFruchter@aftlaw.com) or Sean M. Handron-O’Brien (SHandronobrien@aftlaw.com). You may also call (212) 279-5050.
Abraham, Fruchter & Twersky LLP is a law firm based in New York and maintaining an office in California. The firm’s attorneys have extensive experience litigating on behalf of shareholders and consumers in class action litigations involving corporate misconduct and has been ranked as a leading plaintiffs’ securities litigation firm in the 2020 survey by ISS Securities Class Action Services. Please visit www.aftlaw.com for more information.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HUTCHMED and AstraZeneca Initiate Phase II Trial of ORPATHYS® in Patients with MET Amplified Gastric Cancer
- BlueRush Announces New CFO
- ShotSpotter Responds to False and Misleading Allegations by VICE News
Create E-mail Alert Related CategoriesGlobe Newswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!